H. Lawrence Remmel
CIK: 0001551817
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATOS
ATOSSA THERAPEUTICS, INC.
Director
Discretionary Trading P&L
Holdings
About Remmel H. Lawrence
Remmel H. Lawrence (SEC CIK 0001551817) files insider reports with the SEC as Director of ATOSSA THERAPEUTICS, INC. (ATOS).
Signal8 holds 3 ownership filings by Remmel H. Lawrence, all Form 4s, filed between Mar 28, 2025 and May 14, 2026. Those filings report 3 transactions, from Mar 26, 2025 to May 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Remmel H. Lawrence's filings is in SEATTLE, WA.
Recent filings by Remmel H. Lawrence
Other insiders filing for ATOSSA THERAPEUTICS, INC. (ATOS)
- Steinhart Richard I, Director
- Chen Shu-Chih, Director
- Finn Jonathan, Director
- Galli Stephen J, Director
- Cigler Tessa, Director
- Daniel Mark James, Chief Financial Officer